Equities Analysts Offer Predictions for Hawkins Q1 Earnings

Hawkins, Inc. (NASDAQ:HWKN - Free Report) - Equities researchers at Sidoti Csr raised their Q1 2026 earnings estimates for Hawkins in a report released on Friday, May 16th. Sidoti Csr analyst D. Harriman now expects that the specialty chemicals company will post earnings per share of $1.37 for the quarter, up from their previous forecast of $1.35. The consensus estimate for Hawkins' current full-year earnings is $4.00 per share.

A number of other research firms have also issued reports on HWKN. BWS Financial reaffirmed a "buy" rating and set a $160.00 target price on shares of Hawkins in a report on Thursday, May 15th. CJS Securities began coverage on Hawkins in a research note on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 price target on the stock. Finally, Wall Street Zen cut Hawkins from a "buy" rating to a "hold" rating in a research note on Saturday.

Hawkins Stock Performance

NASDAQ HWKN traded up $1.83 during trading hours on Monday, hitting $128.50. The company had a trading volume of 114,693 shares, compared to its average volume of 124,808. Hawkins has a fifty-two week low of $83.88 and a fifty-two week high of $139.55. The company has a quick ratio of 1.53, a current ratio of 2.50 and a debt-to-equity ratio of 0.23. The business has a fifty day simple moving average of $116.47 and a 200-day simple moving average of $117.67. The firm has a market cap of $2.67 billion, a P/E ratio of 32.78, a price-to-earnings-growth ratio of 3.80 and a beta of 0.87.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.04. Hawkins had a net margin of 8.60% and a return on equity of 18.95%. The company had revenue of $245.32 million during the quarter, compared to the consensus estimate of $230.69 million.

Institutional Investors Weigh In On Hawkins

Institutional investors have recently bought and sold shares of the business. Brooklyn Investment Group lifted its holdings in Hawkins by 533.3% in the 1st quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 224 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in shares of Hawkins by 118.8% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company's stock valued at $30,000 after purchasing an additional 152 shares during the period. Vermillion Wealth Management Inc. bought a new stake in Hawkins in the fourth quarter valued at $34,000. Caitong International Asset Management Co. Ltd bought a new stake in Hawkins in the first quarter valued at $42,000. Finally, Blue Trust Inc. grew its position in Hawkins by 155.4% in the fourth quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company's stock valued at $44,000 after acquiring an additional 216 shares during the period. 69.71% of the stock is currently owned by institutional investors and hedge funds.

Hawkins Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be given a dividend of $0.18 per share. The ex-dividend date is Friday, May 30th. This represents a $0.72 dividend on an annualized basis and a yield of 0.56%. Hawkins's payout ratio is presently 17.82%.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.